Skip to main content

BG Medicine, Boston Scientific Study Galectin-3 for CRT

By a GenomeWeb Staff Reporter

NEW YORK (GenomeWeb News) – BG Medicine today announced a collaboration with Boston Scientific to study whether galectin-3 can be used to screen patients for cardiac-resynchronization therapy.

Data for their effort will come from the MADIT-CRT study, the world's largest randomized study of New York Heart Association Class I and II patients. The study involves more than 1,800 patients enrolled in 110 centers worldwide.

The focus of the collaboration is to better understand the MADIT-CRT patient population and determine whether galectin-3 can help identify patients who would benefit from CRT, BG Medicine said.

Today, patients are selected for CRT based on current cardiac status, not on how disease is expected to progress, Pieter Muntendam, president and CEO of BG Medicine, said in a statement. "Elevated galectin-3 is associated with poor outcomes, and this collaboration aims to investigate the role galectin-3 can play in identifying those who stand to gain most by early use of CRTs," he said.

BG's galectin-3 assay received clearance from the US Food and Drug Administration in November.

As part of the agreement, BG Medicine's capabilities will be used to discover other biomarkers that may correlate to CRT treatment response.

Financial and other terms of the deal were not disclosed.

The Scan

And For Adolescents

The US Food and Drug Administration has authorized the Pfizer-BioNTech SARS-CoV-2 vaccine for children between the ages of 12 and 15 years old.

Also of Concern to WHO

The Wall Street Journal reports that the World Health Organization has classified the SARS-CoV-2 variant B.1.617 as a "variant of concern."

Test for Them All

The New York Times reports on the development of combined tests for SARS-CoV-2 and other viruses like influenza.

PNAS Papers on Oral Microbiome Evolution, Snake Toxins, Transcription Factor Binding

In PNAS this week: evolution of oral microbiomes among hominids, comparative genomic analysis of snake toxins, and more.